Phase I clinical study of anti-apoptosis protein survivin-derived peptide vaccination for patients with advanced or recurrent urothelial cancer (Q51763792)
scientific article published on 18 March 2009
Language:
Current Data About Phase I clinical study of anti-apoptosis protein survivin-derived peptide vaccination for patients with advanced or recurrent urothelial cancer
(P31) (Q13442814)
(P248)
(P698) 19294381
(P813) Wednesday, April 11, 2018
(P854) http://europepmc.org/abstract/MED/19294381

(P50) (Q92999769)
(P1545) 8
(P1932) Naoya Masumori
(P248)
(P698) 19294381
(P813) Wednesday, April 11, 2018
(P854) http://europepmc.org/abstract/MED/19294381

(Q91737677)
(P1545) 3
(P1932) Toshihiko Torigoe
(P248)
(P698) 19294381
(P813) Wednesday, April 11, 2018
(P854) http://europepmc.org/abstract/MED/19294381

(Q89833718)
(P1545) 7
(P1932) Yoshihiko Hirohashi
(P248)
(P698) 19294381
(P813) Wednesday, April 11, 2018
(P854) http://europepmc.org/abstract/MED/19294381

(Q113953738)
(P1545) 10
(P1932) Noriyuki Sato
(P248)
(P698) 19294381
(P813) Wednesday, April 11, 2018
(P854) http://europepmc.org/abstract/MED/19294381

(Q114426864)
(P1545) 4
(P1932) Akari Takahashi
(P248)
(P698) 19294381
(P813) Wednesday, April 11, 2018
(P854) http://europepmc.org/abstract/MED/19294381

(Q88546542)
(P1545) 2
(P1932) Hiroshi Kitamura
(P248)
(P698) 19294381
(P813) Wednesday, April 11, 2018
(P854) http://europepmc.org/abstract/MED/19294381

(Q114426934)
(P1545) 1
(P1932) Ichiya Honma
(P248)
(P698) 19294381
(P813) Wednesday, April 11, 2018
(P854) http://europepmc.org/abstract/MED/19294381

(Q114426935)
(P1545) 9
(P1932) Taiji Tsukamoto
(P248)
(P698) 19294381
(P813) Wednesday, April 11, 2018
(P854) http://europepmc.org/abstract/MED/19294381

(Q92970077)
(P1545) 5
(P1932) Toshiaki Tanaka
(P248)
(P698) 19294381
(P813) Wednesday, April 11, 2018
(P854) http://europepmc.org/abstract/MED/19294381

(P304) 1801-1807
(P248)
(P698) 19294381
(P813) Wednesday, April 11, 2018
(P854) http://europepmc.org/abstract/MED/19294381

(P407) (Q1860)

(P433) 11
(P248)
(P698) 19294381
(P813) Wednesday, April 11, 2018
(P854) http://europepmc.org/abstract/MED/19294381

(P478) 58
(P248)
(P698) 19294381
(P813) Wednesday, April 11, 2018
(P854) http://europepmc.org/abstract/MED/19294381

(P577) Wednesday, March 18, 2009
(P248)
(P698) 19294381
(P813) Wednesday, April 11, 2018
(P854) http://europepmc.org/abstract/MED/19294381

(P1433) (Q5031409)
(P248)
(P698) 19294381
(P813) Wednesday, April 11, 2018
(P854) http://europepmc.org/abstract/MED/19294381

(P1476) "Phase I clinical study of anti-apoptosis protein survivin-derived peptide vaccination for patients with advanced or recurrent urothelial cancer" (language: en)
(P248)
(P698) 19294381
(P813) Wednesday, April 11, 2018
(P854) http://europepmc.org/abstract/MED/19294381

(P2093) Eiji Sato
(P1545) 6
(P248)
(P698) 19294381
(P813) Wednesday, April 11, 2018
(P854) http://europepmc.org/abstract/MED/19294381

(P2860) (Q39432962)
(P248)
(P854) https://api.crossref.org/works/10.1007%2FS00262-009-0691-X
(P813) Sunday, January 21, 2018

(Q39153149)
(P248)
(P854) https://api.crossref.org/works/10.1007%2FS00262-009-0691-X
(P813) Sunday, January 21, 2018

other details
description scientific article published on 18 March 2009

External Links
(P356) 10.1007/S00262-009-0691-X
(P698) 19294381
(P5875) 24208445